Ticker AMPE – Ampio Pharm – sales, description, marketcap – Tickerday.com

AMPE

Ampio Pharm

–

Index: NYSE; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 163.83M; Volume: 391.81K; AvgVol 3m: 4.04M; Beta: 1.65;

Cost estimate:

P/E: –; EPS: -0.11; EPS growth quarter/prev quarter: -563.60%;

EPS growth this year: -122.50%; EPS growth past 5 years: 29.60%;

EPS ttm: -0.11;

P/S: ; P/B: 20.46; P/Cashflow: 32.12; P/FCF: ;

Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -127.50%; ROE – return on equity: -341.50%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 8.65%; Insider Transactions:0.00%;

Institutional Ownership: 12.10%; Institutional Transactions: 6.28%;

Data update: 07/10/2020.